SummitTX Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
SummitTX Capital's JAZZ Position: Q3 2026 in Review
SummitTX Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.3% in Q3 2026, selling an estimated $120K and leaving 35,791 shares worth $8.29M. The position accounts for 0.22% of the portfolio, ranked #110.
SummitTX Capital first reported a position in JAZZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $21.6M in Q4 2025. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- SummitTX Capital held 35,791 shares of Jazz Pharmaceuticals worth $8.29M as of Q3 2026.
- SummitTX Capital sold 485 Jazz Pharmaceuticals shares in Q3 2026, an estimated $120K.
- Jazz Pharmaceuticals made up 0.22% of SummitTX Capital's portfolio in Q3 2026, its #110 holding.
- SummitTX Capital first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SummitTX Capital's Jazz Pharmaceuticals position peaked at $21.6M in Q4 2025.
- 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on SummitTX Capital's 13F filing for Q3 2026, filed 16 Nov 2026.